Hide Board Information

Show Board Information

InMed Pharmaceuticals, Inc. INM

Board Mod: wholelotamoney

Asst Mods:

Last Post: 08/29/2024 4:50:19 PM

Board Marks: 5

Posts Today: 0

Board Views Today: 140

InMed Pharmaceuticals, Inc. (NASDAQ: INM) Stock Message Board

1. INM Company Profile

    

2. INM Time & Sales

    

3. INM Recent News

    

4. INM Filings

    

5. INM Financials

    

6. INM Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

78	$IMLFF News Article - InMed Pharmaceuticals to	whytestocks	03/12/2019 8:11:42 AM
77	12.66% v1,607,018 c.597000 f170,883,630 awesome	znewcar1	02/04/2019 6:38:19 PM
76	13.24% v1,293,760 c.464300 f170,883,630	znewcar1	01/30/2019 4:56:33 PM
75	14.37% v530,356 c.334200 f170,883,630 Broke the	znewcar1	01/04/2019 5:31:29 PM
74	IMLFF has fallen through the $0.3 floor yet has	znewcar1	12/27/2018 9:27:46 AM
73	30% 2.9M C.7724 good vol all	znewcar1	09/10/2018 5:16:51 PM
72	Pot Stock Bull Market Primed for Even More Growth	NetworkNewsWire	12/20/2017 5:57:10 PM
71	Biotech Market Banking on Big Cannabis Returns	NetworkNewsWire	12/19/2017 6:02:22 PM
70	NetworkNewsBreaks InMed Pharmaceuticals, Inc.	NetworkNewsWire	12/18/2017 5:42:55 PM
69	Dangerous Opioid Side Effects Shift Market Focus	NetworkNewsWire	12/13/2017 6:34:23 PM
68	The Therapeutic Potential of Pharmacologically	NetworkNewsWire	12/12/2017 5:41:28 PM
67	NetworkNewsBreaks InMed Pharmaceuticals, Inc.	NetworkNewsWire	12/11/2017 6:35:24 PM
66	NetworkNewsBreaks InMed Pharmaceuticals, Inc.	NetworkNewsWire	12/06/2017 6:09:33 PM
65	Advanced Biosynthesis Setting New Standards for	NetworkNewsWire	12/06/2017 5:30:19 PM
64	Purified Cannabinoids Open New Opportunities in	NetworkNewsWire	12/05/2017 6:18:22 PM
63	NetworkNewsBreaks InMed Pharmaceuticals, Inc.	NetworkNewsWire	11/16/2017 7:48:42 PM
62	Innovation Drives Value for Leading Cannabis	NetworkNewsWire	11/15/2017 5:58:04 PM
61	Biosynthesis: Making the Impossible Possible in	NetworkNewsWire	11/14/2017 5:57:30 PM
60	Cannabis Biotechs Could be Big Pharmas Latest	NetworkNewsWire	11/08/2017 5:52:08 PM
59	Biotech M&A Momentum Attractive for Cannabinoid	NetworkNewsWire	11/07/2017 6:09:16 PM
58	NetworkNewsBreaks InMed Pharmaceuticals, Inc.	NetworkNewsWire	11/03/2017 5:20:13 PM
57	Economic Impact of Biosynthesis on the Cannabis	NetworkNewsWire	10/31/2017 5:20:24 PM
56	Innovative Biotechnology Companies are	NetworkNewsWire	10/26/2017 6:29:54 PM
55	Biotechs Develop Proprietary Systems to Drive CBD	NetworkNewsWire	10/25/2017 6:10:32 PM
54	NetworkNewsBreaks InMed Pharmaceuticals, Inc.	NetworkNewsWire	10/25/2017 4:17:48 AM
53	How Biosynthesis is Revolutionizing Cannabinoid	NetworkNewsWire	10/24/2017 6:10:45 PM
52	InMed Pharmaceuticals, Inc.s (CSE: IN) (OTCQB:	NetworkNewsWire	10/19/2017 5:46:56 PM
51	NetworkNewsBreaks InMed Pharmaceuticals, Inc.	NetworkNewsWire	10/17/2017 6:56:50 PM
50	NetworkNewsBreaks InMed Pharmaceuticals, Inc.	NetworkNewsWire	10/10/2017 6:05:08 PM
49	InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB:	NetworkNewsWire	10/09/2017 5:04:47 PM
48	NetworkNewsBreaks InMed Pharmaceuticals, Inc.	NetworkNewsWire	10/03/2017 6:23:59 PM
47	Cannabinoid Biosynthesis Poised as Potential	NetworkNewsWire	09/28/2017 4:58:33 PM
46	InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB:	NetworkNewsWire	09/27/2017 6:09:35 PM
45	Medical Cannabis Companies Leverage Biosynthesis	NetworkNewsWire	09/26/2017 5:22:04 PM
44	NetworkNewsBreaks InMed Pharmaceuticals, Inc.	NetworkNewsWire	09/26/2017 2:09:04 PM
43	Hi Anybody here ? Anyone else think IMLFF will be	Sherri786	09/24/2017 11:29:56 PM
42	NetworkNewsBreaks InMed Pharmaceuticals, Inc.	NetworkNewsWire	09/21/2017 7:35:09 PM
41	NetworkNewsBreaks InMed Pharmaceuticals, Inc.	NetworkNewsWire	09/19/2017 5:19:19 PM
40	InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB:	NetworkNewsWire	09/14/2017 6:08:34 PM
39	Biosynthesis Technology Could Transform	NetworkNewsWire	09/13/2017 5:09:14 PM
38	NetworkNewsBreaks InMed Pharmaceuticals, Inc.	NetworkNewsWire	09/12/2017 5:21:49 PM
37	Cannabis Biotechs Taking Leading Stance in Global	NetworkNewsWire	09/12/2017 4:44:30 PM
36	NetworkNewsBreaks InMed Pharmaceuticals (CSE:	NetworkNewsWire	09/01/2017 4:58:54 PM
35	NetworkNewsBreaks InMed Pharmaceuticals, Inc.	NetworkNewsWire	08/18/2017 4:43:57 PM
34	InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB:	NetworkNewsWire	08/14/2017 5:49:20 PM
33	InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB:	NetworkNewsWire	08/08/2017 5:37:30 PM
32	NetworkNewsBreaks InMed Pharmaceuticals, Inc.	NetworkNewsWire	07/27/2017 5:17:52 PM
31	InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB:	NetworkNewsWire	07/24/2017 6:07:49 PM
30	NetworkNewsBreaks InMed Pharmaceuticals, Inc.	NetworkNewsWire	07/10/2017 5:18:31 PM
29	InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB:	NetworkNewsWire	07/05/2017 6:40:01 PM

Newer

Older

Recent Articles

• Nokia's Strategic Share Buyback Efforts Highlight Growth Focus
• LiveDeal Stock Hits Record Low: What This Means for Investors
• Citius Pharmaceuticals Faces Challenges Amidst Stock Low at $0.16
• Alcoa's Remarkable Rally: Stock Reaches New Heights
• Market Turmoil Sees Stonebridge Acquisition's FAAS Stock Decline
• Macquarie Insights: Inflation Concerns Rise Post-Election
• Is the Nikkei Index Approaching a 35-Year High? Analysis
• Exxon Mobil Exits Shallow Water Exploration Talks with Guyana
• Revolve Group's Stock Reaches New Heights Amid Growth Surge
• CPAY Stock Hits Record Level, Proving Market Confidence
• Meridian Bank Stock Surges to New Heights Amid Positive Trends
• Natural Alternatives International Stock Hits Yearly Low Amid Struggles
• Adani Group's Gautam Adani: Legal Struggles Ahead
• Legal Obstacles Loom for Google's Chrome Sale Amid Antitrust Movements
• Macquarie Lowers NIO Rating Amid Demand and Guidance Woes
• Bitcoin Rockets Past $98,000: Insights from Michael Saylor
• Walmart's Financial Positive Shift: What Investors Need to Know
• Empowering Future Healthcare Leaders Through Grants
• Exciting Developments in Trump's Crypto Advisory Council Plans
• Solana Surges 10% as New ETF Filings Spark Investor Excitement
• Nano Dimension’s Court Victory: Key Decisions and Board Updates
• Empower Your Career: Online Cannabis Training Launches
• Exploring New Horizons: Callinex Mines Update on Pine Bay Project
• MacKenzie Realty Capital Shares Positive Q1 Updates and Results
• bioAffinity Technologies: Insights into Recent Stock Trends
• Ohio Valley Banc Corp. Stock Achieves New Heights in Performance
• Summit Materials Engaged in Acquisitions: Current Insights
• Surf Air Mobility's Strategic Shift Towards Profitable Operations
• Adagio Therapeutics Faces Challenges Amid Stock Decline
• Northrim BanCorp Achieves Historic Stock Milestone with NRIM Surge
• Swiss National Bank Board Member Confirms Inflation Stability
• Northvolt's Bankruptcy: A Critical Moment for Europe's EV Goals
• Snap's Motion to Dismiss Lawsuit Highlights Child Safety Issues
• Understanding the Costs of Completing Pokémon TCG's First Set
• Transforming Business Potential: Elevate Your Practice Today
• Experience Holiday Magic with Moody Gardens' ICE LAND Event
• Exciting Handover Celebration for Children's Mobility Vehicles
• BusPatrol's Accolades Highlight Commitment to Safety and Innovation
• Exploring the Ancient Psychedelic Practices of Egypt's Bes Mug
• XRP Price Rallies as Market Anticipates Positive Shifts Ahead
• New Models and Amenities Await at Grand Oaks Community
• Key Investor Deadline Approaches in Humacyte Class Action
• Automakers Advocate for EV Tax Credits and Self-Driving Cars
• Globus Medical's Stock Reaches New Heights: A Comprehensive Overview
• CB Financial Services Hits 52-Week High: What It Means
• CVB Financial Initiates Major Stock Buyback Strategy for Investors
• US Lawmakers Challenge Arms Sales Amid Sudan Crisis
• MicroStrategy Embarks on Bold Bitcoin Strategy Amid Market Buzz
• Will Tesla Challenge Nvidia's Leading Stock Performance?
• Debbie Wasserman Schultz's Strategic Trades in Key Companies